×
Close
Sign Up
Login
Home
Library S
Library D
Events & Partner
WeMed
MDLA Events Platform
Events
Media Partners
Educational Partner
User Tools
FAQ/USER GUIDE
Language
English
中文/ Chinese
French
Português
Español
Arabic
Russian
Contact Us
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
Categories
Oncology
52871
Global Medical University
5219
Allergy
1821
Anatomy & Morphology
1577
Andrology
379
Anesthesia & Intensive Care
1305
Anesthesiology
5554
Audiology & Speech-Language Pathology
347
Behavioral Sciences
100
Biochemical Research Methods
7207
Biochemistry & Molecular Biology
30290
Biodiversity Conservation
332
Biology
8570
Biophysics
8387
Biotechnology & Applied Microbiology
8630
Cardiac & Cardiovascular Systems
31415
Cardiovascular & Respiratory Systems
1398
Cell & Tissue Engineering
710
Cell Biology
11337
Chemistry, Analytical
4309
Chemistry, Applied
11081
Chemistry, Medicinal
8772
Chemistry, Multidisciplinary
18622
Clinical Immunology & Infectious Disease
454
Clinical Medicine
9000
Clinical Neurology
16805
Clinical Psychology & Psychiatry
1317
Critical Care Medicine
3254
Dentistry, Oral Surgery & Medicine
13591
Dermatology
7466
Developmental Biology
6984
Ecology
650
Education, Scientific Disciplines
2073
Emergency Medicine
4145
Endocrinology, Metabolism & Nutrition
24671
Engineering, Biomedical
3798
Entomology
457
Environmental Medicine & Public Health
4783
Evolutionary Biology
269
Gastroenterology & Hepatology
12304
General & Internal Medicine
7045
Genetics & Heredity
15221
Geriatrics & Gerontology
5182
Gerontology
375
Health Care Sciences & Services
16259
Health Policy & Services
654
Hematology
5660
Immunology
24954
Infectious Diseases
14128
Integrative & Complementary Medicine
2964
Medical Ethics
1219
Medical Informatics
2290
Medical Laboratory Technology
419
Medicine, General & Internal
44786
Medicine, Legal
534
Medicine, Research & Experimental
17942
Microbiology
23469
Mycology
0
Nanoscience & Nanotechnology
5454
Neuroimaging
1415
Neurology
4600
Neurosciences
40243
Nursing
9796
Nutrition & Dietetics
7924
Obstetrics & Gynecology
8377
Ophthalmology
9828
Optics
4326
Orthopedics
11896
Orthopedics, Rehabilitation & Sports Medicine
1829
Otolaryngology
1593
Otorhinolaryngology
4940
Parasitology
1141
Pathology
5125
Pediatrics
21875
Peripheral Vascular Disease
4922
Pharmacology & Pharmacy
35619
Pharmacology/Toxicology
12205
Physiology
8978
Polymer Science
537
Primary Health Care
873
Psychiatry
19325
Psychology
5296
Psychology, Applied
112
Psychology, Biological
374
Psychology, Clinical
825
Psychology, Developmental
244
Psychology, Educational
169
Psychology, Experimental
169
Psychology, Mathematical
0
Psychology, Multidisciplinary
1706
Psychology, Psychoanalysis
30
Psychology, Social
121
Public Health & Health Care Science
2262
Public, Environmental & Occupational Health
27468
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12596
Radiology, Nuclear Medicine & Medical Imaging
8192
Rehabilitation
3080
Remote Sensing
0
Reproductive Biology
2897
Reproductive Medicine
1208
Research/Laboratory Medicine & Medical Technology
4032
Respiratory System
7546
Rheumatology
6119
Social Sciences, Biomedical
1217
Substance Abuse
2774
Surgery
34294
Toxicology
4490
Transplantation
953
Tropical Medicine
300
Urology & Nephrology
13164
Veterinary Sciences
35
Virology
2494
Zoology
0
Channels
TARGETED ONCOLOGY
263
Pathology Society Understanding disease
52
Asian Journal of Oncology
57
Medrxiv - Oncology
893
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
226
BONE MARROW TRANSPLANTATION
773
BREAST CANCER RESEARCH
299
BREAST CANCER RESEARCH AND TREATMENT
762
BRITISH JOURNAL OF CANCER
1003
CA-A CANCER JOURNAL FOR CLINICIANS
24
CANCER
419
CANCER AND METASTASIS REVIEWS
224
CANCER CELL INTERNATIONAL
903
CANCER DISCOVERY
156
CANCER MEDICINE
456
CANCER PREVENTION RESEARCH
62
CANCER RESEARCH
277
CANCER RESEARCH AND TREATMENT
20
CANCER SCIENCE
237
CANCERS
4428
CLINICAL CANCER RESEARCH
292
CLINICAL EPIGENETICS
456
CURRENT ONCOLOGY REPORTS
415
CURRENT OPINION IN ONCOLOGY
232
CURRENT TREATMENT OPTIONS IN ONCOLOGY
308
EXPERIMENTAL CELL RESEARCH
813
HEMATOLOGICAL ONCOLOGY
152
INTERNATIONAL JOURNAL OF CANCER
292
JOURNAL FOR IMMUNOTHERAPY OF CANCER
1356
JOURNAL OF CANCER
20
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
1044
JOURNAL OF CLINICAL ONCOLOGY
995
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
783
JOURNAL OF HEMATOLOGY & ONCOLOGY
383
JOURNAL OF NEURO-ONCOLOGY
769
JOURNAL OF PATHOLOGY
39
JOURNAL OF SURGICAL ONCOLOGY
240
LEUKEMIA
779
LIVER CANCER
145
MEDICAL ONCOLOGY
388
MOLECULAR CANCER
482
MOLECULAR CANCER THERAPEUTICS
157
MOLECULAR ONCOLOGY
201
NATURE REVIEWS CANCER
316
NATURE REVIEWS CLINICAL ONCOLOGY
339
NEOPLASIA
279
ONCOGENE
974
ONCOGENESIS
182
ONCOLOGIST
204
ONCOLOGY-NEW YORK
73
ONCOTARGETS AND THERAPY
592
PSYCHO-ONCOLOGY
158
SURGICAL ONCOLOGY-OXFORD
359
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
103
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
150
BMC CANCER
1897
CANCER EPIDEMIOLOGY
446
CANCER GENETICS
31
CANCER MANAGEMENT AND RESEARCH
1015
CURRENT ONCOLOGY
803
FRONTIERS IN ONCOLOGY
10147
FUTURE ONCOLOGY
111
GENES CHROMOSOMES & CANCER
50
HEREDITARY CANCER IN CLINICAL PRACTICE
97
INFECTIOUS AGENTS AND CANCER
190
INTEGRATIVE CANCER THERAPIES
69
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
670
JOURNAL OF BUON
25
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
294
JOURNAL OF HEPATOCELLULAR CARCINOMA
428
ONCOLOGY
93
ONCOLOGY RESEARCH AND TREATMENT
164
PEDIATRIC BLOOD & CANCER
403
SEMINARS IN ONCOLOGY NURSING
282
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
204
THORACIC CANCER
271
TUMORI J
67
INDIAN JOURNAL OF CANCER
122
JOURNAL OF ONCOLOGY PRACTICE
436
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
970
RADIATION ONCOLOGY
528
WORLD CANCER RESEARCH JOURNAL
146
SOUTH ASIAN JOURNAL OF CANCER
319
BREAST CANCER-BASIC AND CLINICAL RESEARCH
19
CANCER REPORTS
164
CASE REPORTS IN ONCOLOGY
348
CLINICAL CANCER INVESTIGATION JOURNAL
10
CURRENT BREAST CANCER REPORTS
96
CURRENT CANCER THERAPY REVIEWS
16
CURRENT COLORECTAL CANCER REPORTS
29
INDIAN JOURNAL OF SURGICAL ONCOLOGY
550
INTERNATIONAL CANCER CONFERENCE JOURNAL
200
INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY
18
JMIR CANCER
218
JOURNAL OF GASTROINTESTINAL CANCER
406
JOURNAL OF KIDNEY CANCER AND VHL
92
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE
138
RARE TUMORS
23
REHABILITATION ONCOLOGY
109
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
251
MIDDLE EAST JOURNAL OF CANCER
202
NATURE CANCER
437
ONCOLOGY AND THERAPY
122
ONCOLOGY REVIEWS
36
ONKOLOGIJA
39
HORMONES & CANCER / DISCOVER ONCOLOGY
221
FAMILIAL CANCER
166
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
518
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
96
MEDICAL ONCOLOGY
400
PATHOLOGY & ONCOLOGY RESEARCH
39
PSYCHO-ONCOLOGIE
20
STRAHLENTHERAPIE UND ONKOLOGIE
425
SUPPORTIVE CARE IN CANCER
1182
SCI Abstract
search
ALL
RECOMMENDED
+
Niraparib Maintenance Therapy in Patients with Platinum-Sensitive Recurrent Ovarian Cancer: Real-World Experience at Hospitals in Spain
The reported benefit of poly (ADP‐ribose) polymerase inhibitor (PARPi) maintenance in patients with newly diagnosed ...
Targeted Oncology
comment
0
thumb_up
0
Multiple Myeloma: Improved Outcomes Resulting from a Rapidly Expanding Number of Therapeutic Options
Multiple myeloma (MM) is a bone-marrow-based cancer of plasma cells. Over the last 2 decades, marked treatment advances ha...
Targeted Oncology
comment
0
thumb_up
0
The User’s Guide to Amivantamab
Targeted therapies have revolutionized treatment of non-small-cell lung cancer (NSCLC); however, epidermal growth factor r...
Targeted Oncology
comment
0
thumb_up
0
Checkpoint Inhibition Prior to Stem Cell Transplantation Increases the Risk of Inflammatory Adverse Events
Stem cell transplantation (SCT) and immune checkpoint inhibitors (ICIs) are both used in the treatment of hematological ma...
Targeted Oncology
comment
0
thumb_up
0
Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple Myeloma
Elranatamab is a BCMA-CD3 bispecific antibody approved for the treatment of relapsed or refractory multiple myeloma. Cytok...
Targeted Oncology
comment
0
thumb_up
0
The Development of ATM Inhibitors in Cancer Therapy
The ataxia-telangiectasia mutated (ATM) protein kinase plays a critical role in activating the cellular response to DNA do...
Targeted Oncology
comment
0
thumb_up
0
Leveraging the Immunomodulatory Potential of Ibrutinib for Improved Outcomes of T Cell-Mediated Therapies of B Cell Malignancies: A Narrative Review
Standard treatment options for B cell malignancies include immunochemotherapies and/or targeted therapies, which ...
Targeted Oncology
comment
0
thumb_up
0
Compassionate Access to Brigatinib for Patients with Non-small-cell Lung Cancer Harboring a Rearrangement: Results from the BRIGAROS Study
ROS1 chromosomic rearrangement is a rare oncogenic driver, and patients with this rearrangement benefit from specific targ...
Targeted Oncology
comment
0
thumb_up
0
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors
Chemotherapy plus epidermal growth factor receptor (EGFR) inhibitors, such as cetuximab, is standard therapy for KRAS wild...
Targeted Oncology
comment
0
thumb_up
0
Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial
The gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix is the only oral androgen deprivation therapy (ADT...
Targeted Oncology
comment
0
thumb_up
0
Immunotherapy for Renal Cell Carcinoma—What More is to Come?
The treatment of renal cell carcinoma (RCC), a malignancy that is typically chemoresistant, has drastically evolved with t...
Targeted Oncology
comment
0
thumb_up
0
The Impact of Uncommon HRR Alterations as Predictors of Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials
Metastatic castration-resistant prostate cancer (mCRPC) patients with BRCA1/2 mutations show significant responses to poly...
Targeted Oncology
comment
0
thumb_up
0
Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure
The efficacy of immune checkpoint inhibitor (ICI) monotherapy on non-small-cell lung cancer (NSCLC) varies by epidermal gr...
Targeted Oncology
comment
0
thumb_up
0
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab
Atezolizumab is a programmed death-ligand 1 (PD-L1) checkpoint inhibitor for the treatment of different forms of cancer. T...
Targeted Oncology
comment
0
thumb_up
0
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan
The antibody–drug conjugate sacituzumab govitecan is approved for metastatic triple-negative breast cancer and has s...
Targeted Oncology
comment
0
thumb_up
0
Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics
Diffuse-type gastric cancer (DGC) accounts for approximately one-third of gastric cancer diagnoses but is a more clinicall...
Targeted Oncology
comment
0
thumb_up
0
Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model
Cytokine release syndrome, commonly associated with T-cell immunotherapies, was observed with talquetamab, a T-cell-redire...
Targeted Oncology
comment
0
thumb_up
0
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)
Therapeutic advancements based on immuno-oncology combinations have revolutionized the management of patients with renal c...
Targeted Oncology
comment
0
thumb_up
0
Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01
Osimertinib shows higher effectiveness than first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhib...
Targeted Oncology
comment
0
thumb_up
0
The Epidemiology of Biliary Tract Cancer and Associated Prevalence of MDM2 Amplification: A Targeted Literature Review
Biliary tract cancer (BTC) is a rare and aggressive malignancy that is anatomically classified as gallbladder cancer (GBC)...
Targeted Oncology
comment
0
thumb_up
0
Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial
Neurotrophic tyrosine receptor kinase (NTRK) gene fusions represent rare somatic mutations in many types of cancer and hav...
Targeted Oncology
comment
0
thumb_up
0
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study
Enfortumab vedotin (EV) has been approved for the treatment of patients with locally advanced/metastatic urothelial carcin...
Targeted Oncology
comment
0
thumb_up
0
Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific
Atezolizumab-bevacizumab is a standard first-line treatment for unresectable hepatocellular carcinoma (uHCC). Given the di...
Targeted Oncology
comment
0
thumb_up
0
Single-Hit and Multi-hit PIK3CA Short Variant Genomic Alterations in Clinically Advanced Prostate Cancer: A Genomic Landscape Study
Tumors harboring two or more PIK3CA short variant (SV) (“multi-hit”) mutations have been linked to improved ou...
Targeted Oncology
comment
0
thumb_up
0
Taiwan Nationwide Study of First-Line ALK–TKI Therapy in ALK-Positive Lung Adenocarcinoma
The clinical outcomes of patients with anaplastic lymphoma kinase-positive (ALK+) advanced lung adenocarcinoma vary accord...
Targeted Oncology
comment
0
thumb_up
0
Pancreatitis in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Immune checkpoint inhibitors (ICIs) occasionally cause immune-related adverse events (AEs), which pose challenges to the c...
Targeted Oncology
comment
0
thumb_up
0
Risk and Benefit for Basket Trials in Oncology: A Systematic Review and Meta-Analysis
Oncology research is increasingly adopting new clinical trial models that implement the concept of precision medicine. One...
Targeted Oncology
comment
0
thumb_up
0
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab
In the context of patients with hepatocellular carcinoma (HCC) treated with systemic therapy, the correlation between the ...
Targeted Oncology
comment
0
thumb_up
0
Impact of PD-L1 Expression on the Overall Survival of Caucasian Patients with Advanced EGFR-Mutant NSCLC Treated with Frontline Osimertinib
The treatment of advanced non-small cell lung cancer (NSCLC) harboring an oncogenic epidermal growth factor receptor mutat...
Targeted Oncology
comment
0
thumb_up
0
Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review
Patients with follicular lymphoma, an indolent form of non-Hodgkin lymphoma, typically experience multiple relapses over t...
Targeted Oncology
comment
0
thumb_up
0
Load More
Modal title
×
Modal title
×
Share
Login
Global News and Health Forum
Join Now!
Member Login
Remember me
Forgot password?
Or using
Linkedin